drugset / Trial / NCT02586402
Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and efficacy of multiple intravenous doses of pegol-Sihematide in participants with chronic kidney disease (CKD) who are on dialysis.
Timeline
- Start
- 2015-10
- Primary completion
- 2016-08
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegol-Sihematide | Unknown | — | Intravenous |
| Comparator | epoetin alfa | Protein / enzyme biologic | — | — |